Showing results (1441-1450 of 2,132) with videos related to
Sort By:
Pageof 214
The Western Journal of Emergency Medicine|May 20, 2015
Physician documentation of sepsis syndrome is associated with more aggressive treatmentLisa R Stoneking, John P Winkler, Lawrence A DeLuca, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 13, 2018
Regional tract-specific white matter hyperintensities are associated with patterns to aging-related brain atrophy via vascular risk factors, but also independentlyMohamad Habes, Guray Erus, Jon B Toledo, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2017
18F-Flortaucipir PET/MRI Correlations in Nonamnestic and Amnestic Variants of Alzheimer DiseaseIlya M Nasrallah, Yin Jie Chen, Meng-Kang Hsieh, et al.Diabetes Care|September 20, 2007
Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical trainingMatthias Blüher, Catherine J Williams, Nora Klöting, et al.Science Translational Medicine|September 27, 2013
IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasisKerstin Wolk, Katrin Witte, Ellen Witte, et al.American Journal of Clinical Dermatology|March 31, 2026
Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical StudiesMaryanne Senna, Jennifer Soung, Ignasi Figueras, et al.Journal of Applied Microbiology|January 14, 2014
Multicenter evaluation of the Sepsityper™ extraction kit and MALDI-TOF MS for direct identification of positive blood culture isolates using the BD BACTEC™ FX and VersaTREK(®) diagnostic blood culture systemsK M Schieffer, K E Tan, P D Stamper, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 23, 2025
Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO-LT phase 3, open-label studyC Tziotzios, R Sinclair, A Lesiak, et al.American Journal of Alzheimer'S Disease and Other Dementias|December 24, 2013
Subjective memory complaints, cognitive performance, and psychological factors in healthy older adultsSusanne I Steinberg, Selamawit Negash, Mary D Sammel, et al.Nature Medicine|May 14, 2026
Performance of traumatic encephalopathy syndrome criteria in identifying individuals with chronic traumatic encephalopathyJohn D Arena, William Stewart, Andrea L C Schneider, et al.Pageof 214